Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ta-2005 (1 trial)
Lung Diseases (Phase 2)
Lung Diseases, Obstructive (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Trials (1 total)
Trial APIs (1 total)